NCT00002748View on ClinicalTrials.gov

Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 31, 1991

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

gene-modified tumor cell vaccine therapy

BIOLOGICAL

interleukin-2 gene

Trial Locations (1)

38105-2794

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER